| # | Drug | Count |
|---|---|---|
| 0 | DOCETAXEL | 6718 |
| 1 | DOCETAXEL ANHYDROUS | 6718 |
| 2 | TRASTUZUMAB | 1430 |
| 3 | BIMATOPROST | 1395 |
| 4 | DOXORUBICIN HYDROCHLORIDE | 930 |
| 5 | LISINOPRIL | 613 |
| 6 | CARBOPLATIN | 565 |
| 7 | ANASTROZOLE | 553 |
| 8 | METFORMIN | 451 |
| 9 | LEVOTHYROXINE SODIUM | 450 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOCETAXEL ANHYDROUS | 6718 | 0.0987 |
| 1 | DOCETAXEL | 6718 | 0.0987 |
| 2 | TITANIUM DIOXIDE | 13 | 0.0535 |
| 3 | BIMATOPROST | 1395 | 0.0483 |
| 4 | PEGFILGRASTIM | 367 | 0.0306 |
| 5 | DOXORUBICIN HYDROCHLORIDE | 930 | 0.0282 |
| 6 | TRASTUZUMAB | 1430 | 0.0206 |
| 7 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 21 | 0.0185 |
| 8 | EPIRUBICIN HYDROCHLORIDE | 102 | 0.0157 |
| 9 | ANASTROZOLE | 553 | 0.0149 |
| # | Drug class | Count |
|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 6742 |
| 1 | Prostaglandin Analog [EPC] | 1489 |
| 2 | HER2/neu Receptor Antagonist [EPC] | 1447 |
| 3 | Aromatase Inhibitor [EPC] | 990 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 826 |
| 5 | Benzodiazepine [EPC] | 759 |
| 6 | Corticosteroid [EPC] | 660 |
| 7 | Platinum-based Drug [EPC] | 573 |
| 8 | Proton Pump Inhibitor [EPC] | 430 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 410 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 6742 | 0.0406 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 1447 | 0.0193 |
| 2 | Prostaglandin Analog [EPC] | 1489 | 0.0160 |
| 3 | Provitamin D2 Compound [EPC] | 405 | 0.0136 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 100 | 0.0115 |
| 5 | Aromatase Inhibitor [EPC] | 990 | 0.0087 |
| 6 | Ectoparasiticide [EPC] | 29 | 0.0074 |
| 7 | Hedgehog Pathway Inhibitor [EPC] | 60 | 0.0064 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 10 | 0.0048 |
| 9 | Potassium-sparing Diuretic [EPC] | 59 | 0.0044 |